scispace - formally typeset
C

Carol A. Miller

Researcher at University of Southern California

Publications -  110
Citations -  13999

Carol A. Miller is an academic researcher from University of Southern California. The author has contributed to research in topics: Alzheimer's disease & Amyloid beta. The author has an hindex of 50, co-authored 103 publications receiving 12351 citations. Previous affiliations of Carol A. Miller include University of California, San Francisco & California Institute of Technology.

Papers
More filters
Journal ArticleDOI

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Adam C. Naj, +156 more
- 01 May 2011 - 
TL;DR: The Alzheimer Disease Genetics Consortium performed a genome-wide association study of late-onset Alzheimer disease using a three-stage design consisting of a discovery stage (stage 1), two replication stages (stages 2 and 3), and both joint analysis and meta-analysis approaches were used.
Journal ArticleDOI

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

TL;DR: It is concluded that the BBB removes Ass from the brain largely via age-dependent, LRP-1-mediated transport that is influenced by alpha(2)M and/or apoE, and may be impaired in AD.
Journal ArticleDOI

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Rebecca Sims, +487 more
- 01 Sep 2017 - 
TL;DR: Three new genome-wide significant nonsynonymous variants associated with Alzheimer's disease are observed, providing additional evidence that the microglia-mediated innate immune response contributes directly to the development of Alzheimer's Disease.
Journal ArticleDOI

Optic-Nerve Degeneration in Alzheimer's Disease

TL;DR: The changes observed in the patients with Alzheimer's disease were clearly distinguishable from the findings in 10 age-matched controls and represent a sensory-system degeneration that occurs in Alzheimer’s disease.
Journal ArticleDOI

Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model

TL;DR: The discovery of Aβ specific plaques in retinas from AD patients, and the ability to noninvasively detect individual retinal plaque in live AD mice establish the basis for developing high-resolution optical imaging for early AD diagnosis, prognosis assessment and response to therapies.